Vnitr Lek 2015, 61(10):868-872

Management of hypothyroidism and hyperthyroidism

Jan Jiskra
III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Functional thyropathies present significant health risks for patients. Advanced functional thyropathies are always treated while indications for therapy of subclinical thyropathies are individual and often controversial. It is widely agreed that these disorders should be diagnosed and individuals should be followed. The drug of choice in substitution therapy of hypothyroidism is levothyroxine, in the treatment of hyperthyroidism it is methimazole. Administration of propylthiouracil should be limited to the first trimester of pregnancy, because its serious hepatotoxicity has been described. Hyperthyroidism based on thyroid nodules and immunogenic hyperthyroidism not reaching long-term remission, need to be treated radically: by surgery or radioiodine treatment. When radiation protection requirements are met, radioiodine can also be administered on an outpatient basis. Exceptionally, small doses of methimazole can be administered over an extended period of time in individual cases.

Keywords: hyperthyroidism; hypothyroidism; levothyroxine; methimazole; propylthiouracil; radioiodine 131I; total thyroidectomy; thyroid stimulating hormone

Received: August 17, 2015; Accepted: September 25, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jiskra J. Management of hypothyroidism and hyperthyroidism. Vnitr Lek. 2015;61(10):868-872.
Download citation

References

  1. Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Endocrinol (Oxf) 2014; 81(5): 633-641. Go to original source... Go to PubMed...
  2. Bahn RS, Burch HB, Cooper DS et al. American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011; 17(3): 456-520. Go to original source... Go to PubMed...
  3. Cooper DS, Doherty GM, Haugen BR et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19(11): 1167-1214. Go to original source... Go to PubMed...
  4. DeGroot L, Abalovich M, Alexander EK et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society practice guidelines. J Clin Endocrinol Metab 2012; 97(8): 2543-2565. Go to original source... Go to PubMed...
  5. Garber JR, Cobin RH, Gharib H et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 18(6): 988-1028. Go to original source... Go to PubMed...
  6. Jiskra J, Kubinyi J, Telička Z. Léčba hypertyreóza radiojódem 131I v ambulantním režimu - bezpečná, účinná a ekonomická varianta. Vnitř Lék 2012; 58(2): 94-98. Go to PubMed...
  7. Jonklaas J, Bianco AC, Bauer AJ et al. Guidelines for the treatment of hypothyroidism. Thyroid 2014; 24(12):1670-1751. Go to original source... Go to PubMed...
  8. Límanová Z et al. Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility. Klin Biochem Metab 2013; 21(42): 41-64.
  9. Malozowszki S, Chiesa A. Propylthiuracil-induced hepatotoxicity and death. Hopefully, never more. JCEM 2010; 95(7): 3161-3163. Go to original source... Go to PubMed...
  10. Pearce SH, Brabant G, Duntas LH et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J 2013; 2(4): 215-228. Go to original source... Go to PubMed...
  11. Wiersinga WM, Duntas L, Fadeyev V et al. 2012 ETA Guidelines: The use of LT4 + LT3 in the treatment of hypothyroidism. Eur Thyroid J 2012; 1(2): 55-71. Go to original source... Go to PubMed...
  12. Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid 1999; 9(12): 1167-1174. Go to original source... Go to PubMed...
  13. Zamrazil V. Nemoci štítné žlázy v klinické praxi. Postgraduální medicina 2013; 15(7): 720-729.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.